Effects of continual oxytocin treatment on core social symptoms in children with autism with and without comorbid intellectual disability: A verification trial with long-term follow-up KU Leuven
Intranasal administration of the neuropeptide oxytocin (OT) is a therapeutic option targeting the impairments in autism spectrum disorder (ASD). While initial proof-of concept studies have shown improved functioning after multiple-dose OT treatment in children with ASD (<12 years), confirmatory studies are needed in larger cohorts and to study long-term effects. Moreover, most of the studies excluded autistic individuals with comorbid ...